Skip to search boxSkip to navigationSkip to main content

alpha-Actinin interacts with rapsyn in agrin-stimulated AChR clustering.

  • G. Clement Dobbins(corresponding author)
    ,
  • Shiwen Luo
    ,
  • Zhihua Yang
    ,
  • Wen C. Xiong
    ,
  • Lin Mei
*Corresponding author for this work
  • Medical College of Georgia
    ,
  • Unknown
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Abstract

AChR is concentrated at the postjunctional membrane at the neuromuscular junction. However, the underlying mechanism is unclear. We show that α-actinin, a protein known to cross-link F-actin, interacts with rapsyn, a scaffold protein essential for neuromuscular junction formation. α-Actinin, rapsyn, and surface AChR form a ternary complex. Moreover, the rapsyn-α-actinin interaction is increased by agrin, a factor known to stimulate AChR clustering. Downregulation of α-actinin expression inhibits agrin-mediated AChR clustering. Furthermore, the rapsyn-α-actinin interaction can be disrupted by inhibiting Abl and by cholinergic stimulation. Together these results indicate a role for α-actinin in AChR clustering.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Page 18 (1 page)

Journal (Volume, Issue Number)

Molecular brain (Volume 1)

Publication milestones

  • Published - 2008

Publication status

Published - 2008

ISSN

1756-6606

Publication IDs

  • Scopus: 76949086546
  • PubMed: 19055765

Publication metrics

Metrics

SciVal
citations
32
Fractional count
2
Fractional count
0.40
Fractional count
3
Fractional count
0.60
Fractional count
2
Fractional count
1
Scopus
citations
SciVal
FWCI
0.57
SciVal
Author count
5
SciVal
Paper percentile
82

PlumX, opens in new tab

Citation count
42
Captures
41

Funding Details

This work is support in part by grants from NIH (L.M. and W.C.X) and the Muscular Dystrophy Association (L.M.). Special thanks to Dr. E. Olson for the original calsarcin construct, Dr. W.C. Hsu and Dr. A. Woods for the original α-actinin construct, Dr. C. Fuhrer for rapsyn -/-muscle cells; Dr. J. Lindstrom for anti-AChR β-subunit antibody, and Novartis for Sti-571.
FundersFunding number
NIH
-
NINDS
R01NS040480
MDA
-